|
Re: Two Thoughts - 250 and 270
|
2
|
Resverlogix Corp.
|
Dec 14, 2018 05:26AM
|
|
Re: No love
|
3
|
Resverlogix Corp.
|
Dec 13, 2018 12:59PM
|
|
Re: No love
|
3
|
Resverlogix Corp.
|
Dec 13, 2018 12:39PM
|
|
Re: No love
|
2
|
Resverlogix Corp.
|
Dec 13, 2018 12:31PM
|
|
Re: The runway is clear....
|
1
|
Resverlogix Corp.
|
Dec 06, 2018 07:05AM
|
|
Are statins overprescribed? Why the risks and benefits are so complex
|
3
|
Resverlogix Corp.
|
Dec 04, 2018 10:17AM
|
|
Re: Did another Seeking Alpha Instablog post...
|
3
|
Resverlogix Corp.
|
Dec 03, 2018 11:12AM
|
|
Re: Mace Events Study / Type 2 Diabetes / Control Arms 26 CVOT Trials
|
2
|
Resverlogix Corp.
|
Nov 29, 2018 01:31PM
|
|
Re: Mace Events Study / Type 2 Diabetes / Control Arms 26 CVOT Trials
|
4
|
Resverlogix Corp.
|
Nov 29, 2018 11:24AM
|
|
Re: Happy Thanksgiving to all our American friends
|
6
|
Resverlogix Corp.
|
Nov 22, 2018 10:36AM
|
|
Re: Apabetalone downregulates factors and pathways associated with vascular calcification
|
3
|
Resverlogix Corp.
|
Nov 20, 2018 10:53AM
|
|
Re: Zenith and Pfizer collaboration news
|
3
|
Resverlogix Corp.
|
Nov 20, 2018 10:12AM
|
|
Re: Zenith and Pfizer collaboration news
|
2
|
Resverlogix Corp.
|
Nov 20, 2018 09:47AM
|
|
Re: Zenith and Pfizer collaboration news
|
1
|
Resverlogix Corp.
|
Nov 20, 2018 09:42AM
|
|
Re: If this trial were made up of ONLY placebo patients,..
|
1
|
Resverlogix Corp.
|
Nov 19, 2018 02:52PM
|
|
If this trial were made up of ONLY placebo patients,..
|
1
|
Resverlogix Corp.
|
Nov 19, 2018 02:21PM
|
|
It almost looks like the stock is supported at the $3 CAD level
|
3
|
Resverlogix Corp.
|
Nov 19, 2018 10:24AM
|
|
Re: Possible Zenith deal,..
|
2
|
Resverlogix Corp.
|
Nov 17, 2018 03:12PM
|
|
Possible Zenith deal,..
|
4
|
Resverlogix Corp.
|
Nov 17, 2018 02:41PM
|
|
Re: apabetalone and colorectal cancer
|
5
|
Resverlogix Corp.
|
Nov 13, 2018 01:01AM
|
